Word

TETRIDA

Status

Pending

Status Code

730

Status Date

Thursday, November 9, 2023

Serial Number

97371918

Mark Type

4000

Filing Date

Wednesday, April 20, 2022

Published for Opposition

Tuesday, March 21, 2023

Trademark Owner History

TEVA PHARMACEUTICALS USA, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; Antiretroviral drug for the treatment of HIV-1 infection

Trademark Events

Nov 11, 2023

Notice Of Approval Of Extension Request E-Mailed

Nov 9, 2023

Sou Extension 1 Granted

Nov 9, 2023

Sou Extension 1 Filed

Nov 9, 2023

Sou Teas Extension Received

May 16, 2023

Noa E-Mailed - Sou Required From Applicant

Mar 21, 2023

Official Gazette Publication Confirmation E-Mailed

Mar 21, 2023

Published For Opposition

Mar 1, 2023

Notification Of Notice Of Publication E-Mailed

Feb 14, 2023

Approved For Pub - Principal Register

Feb 2, 2023

Teas Change Of Correspondence Received

Feb 2, 2023

Teas Withdrawal Of Attorney Received-Firm Retains

Feb 2, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Feb 2, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Feb 1, 2023

Examiner's Amendment Entered

Feb 1, 2023

Notification Of Examiners Amendment E-Mailed

Feb 1, 2023

Examiners Amendment E-Mailed

Feb 1, 2023

Examiners Amendment -Written

Jan 24, 2023

Assigned To Examiner

Jul 7, 2022

Teas Change Of Correspondence Received

Jul 7, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Jul 7, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Apr 26, 2022

New Application Office Supplied Data Entered

Apr 23, 2022

New Application Entered